THE WELFARE IMPACT OF PARALLEL IMPORTS: A STRUCTURAL APPROACH APPLIED TO THE GERMAN MARKET FOR ORAL ANTI‐DIABETICS

Tomaso Duso, Annika Herr and Moritz Suppliet

Health Economics, 2014, vol. 23, issue 9, 1036-1057

Abstract: We investigate the welfare impact of parallel imports using a large panel dataset containing monthly information on sales, ex‐factory prices, and further product characteristics for all 649 anti‐diabetic drugs sold in Germany between 2004 and 2010. We estimate a two‐stage nested logit model of demand, and on the basis of an oligopolistic model of multi‐product firms, we then recover the marginal costs and markups. We finally evaluate the effect of the parallel imports' policy by calculating a counterfactual scenario without parallel trade. According to our estimates, parallel imports reduce the prices for patented drugs by 11% and do not have a significant effect on prices for generic drugs. This amounts to an increase in the demand‐side surplus by €19 million per year (or €130 million in total), which is relatively small compared with the average annual market size of around €227 million based on ex‐factory prices. The variable profits for the manufacturers of original drugs from the German market are reduced by €18 million (or 37%) per year when parallel trade is allowed, yet only one third of this difference is appropriated by the importers. Copyright © 2014 John Wiley & Sons, Ltd.

Date: 2014
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (29)

Downloads: (external link)
https://doi.org/10.1002/hec.3068

Related works:
Working Paper: The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-Diabetics (2014)
Working Paper: The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-diabetics (2014)
Working Paper: The welfare impact of parallel imports: A structural approach applied to the German market for oral anti-diabetics (2014)
Working Paper: The welfare impact of parallel imports: A structural approach applied to the German market for oral antidiabetics (2014)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:hlthec:v:23:y:2014:i:9:p:1036-1057

Access Statistics for this article

Health Economics is currently edited by Alan Maynard, John Hutton and Andrew Jones

More articles in Health Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().